Genetic Signatures (ASX:GSS) Total Liabilities : A$3.95 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures Total Liabilities?

Genetic Signatures's Total Liabilities for the quarter that ended in Dec. 2023 was A$3.95 Mil.

Genetic Signatures's quarterly Total Liabilities increased from Dec. 2022 (A$4.48 Mil) to Jun. 2023 (A$6.16 Mil) but then declined from Jun. 2023 (A$6.16 Mil) to Dec. 2023 (A$3.95 Mil).

Genetic Signatures's annual Total Liabilities increased from Jun. 2021 (A$4.71 Mil) to Jun. 2022 (A$4.85 Mil) and increased from Jun. 2022 (A$4.85 Mil) to Jun. 2023 (A$6.16 Mil).

Genetic Signatures Total Liabilities Historical Data

The historical data trend for Genetic Signatures's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures Total Liabilities Chart

Genetic Signatures Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Liabilities

Get a 7-Day Free Trial

1.56

3.79

4.71

4.85

6.16

Genetic Signatures Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial													3.93	4.85	4.48	6.16	3.95

Genetic Signatures Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Genetic Signatures's Total Liabilities for the fiscal year that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6.069	+	(0	+	-2.4980018054066E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.095)
	=	6.16

Total Liabilities	=	Total Assets (A: Jun. 2023 )	-	Total Equity (A: Jun. 2023 )
	=	49.078	-	42.914
	=	6.16

Genetic Signatures's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.83	+	(0	+	0.124
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.95

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	44.455	-	40.501
	=	3.95

Genetic Signatures Total Liabilities Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Genetic Signatures (ASX:GSS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042

Website

https://www.geneticsignatures.com

Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.